Aptinyx Return on Equity

Aptinyx (APTX) currently reports a ROE of -159.76%. That is below the Healthcare sector average of 22.13%. Use the charts on this page to explore Aptinyx's ROE history and peer comparisons.

Aptinyx's ROE of -159.76% is lower than the Healthcare sector average of 22.13%. That is roughly 822.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Aptinyx's current -159.76% should be judged against Healthcare norms (sector average: 22.13%) and against APTX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -159.76%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.13%. From there, open related valuation or income-statement pages for Aptinyx, and consider following APTX for alerts when major investors trade the stock.

Aptinyx is classified in the Healthcare sector. On ROE, it currently shows -159.76% versus a sector average near 22.13%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing APTX with unrelated industries.